Agilon Health, Inc. (NYSE:AGL) Stock Has Consensus Price Target of $102.25

Agilon Health, Inc. (NYSE:AGL) has received an average recommendation of “Hold” from the fourteen analysts that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $102.25.

A number of analysts have commented on AGL shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a report on Monday, August 24th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and increased their price target for the company from $105.00 to $115.00 in a research note on Monday, August 10th. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $86.00 to $125.00 in a research report on Tuesday, September 15th. Benchmark reaffirmed a “buy” rating and issued a $140.00 price target (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Finally, Robert W. Baird set a $116.00 price target on Agilon Health in a research note on Thursday, August 6th.

Institutional Trading of Agilon Health

A number of large investors have recently made changes to their positions in the company. Tidal Investments LLC acquired a new stake in Agilon Health during the 2nd quarter worth $1,405,000. Rubicon Founders LLC bought a new position in Agilon Health during the second quarter worth about $11,290,448. State Street Corp bought a new position in Agilon Health during the second quarter worth about $30,024,000. Ellsworth Advisors LLC acquired a new position in Agilon Health in the third quarter valued at about $809,000. Finally, Great Lakes Advisors LLC acquired a new position in Agilon Health in the second quarter valued at about $702,000.

Agilon Health Stock Up 8.9%

NYSE AGL opened at $95.62 on Friday. The stock’s 50 day simple moving average is $87.43 and its 200 day simple moving average is $65.85. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. Agilon Health has a one year low of $7.48 and a one year high of $133.04. The firm has a market cap of $1.61 billion, a PE ratio of -6.70 and a beta of 3.10.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of ($1.23) by $3.20. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.46 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. As a group, sell-side analysts forecast that Agilon Health will post -2.90 earnings per share for the current fiscal year.

Agilon Health News Roundup

Here are the key news stories impacting Agilon Health this week:

• Positive Sentiment: Agilon reported third-quarter earnings of $1.97 per share, versus analyst expectations for a loss, and revenue of $1.52 billion, above the $1.46 billion forecast. Earnings also improved from a $6.75-per-share loss a year earlier. The results point to meaningful progress, though estimates cited in reports differed. Zacks earnings report
• Positive Sentiment: The company’s full-year outlook slightly exceeded expectations, adding support to the positive reaction to the quarterly results. Full-year outlook report
• Negative Sentiment: Despite the per-share earnings beat, Agilon still reported a negative net margin and negative return on equity, indicating that broader profitability remains a concern. Quarterly financial details

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.